相关实验视频

Updated: Jun 13, 2025

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

纽约-ESO-1抗原:癌症免疫治疗中的一个有前途的前沿

Alaa Alsalloum^1,2, Julia A Shevchenko¹, Sergey Sennikov^1,3

¹Laboratory of Molecular Immunology, Federal State Budgetary Scientific Institution Research Institute of Fundamental and Clinical Immunology, Novosibirsk, Russia.

Clinical and translational medicine

|September 14, 2024

概括

纽约食道状细胞癌-1 (NY-ESO-1) 蛋白质是癌症免疫治疗的有希望的标,因为它具有免疫性. 目前正在开发各种NY-ESO-1向策略,包括疫苗和T细胞疗法,以提高癌症治疗效率.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物化学生物化学

背景情况:

瘤相关抗原 (TAA) 对向癌症治疗至关重要.
纽约食道状细胞癌-1 (NY-ESO-1) 是一种癌症/丸抗原,在癌细胞和生殖细胞中表达受限.
NY-ESO-1 作为TAA和内源辅助剂,产生强烈的免疫反应.

研究的目的:

为提供NY-ESO-1作为免疫性瘤抗原的全面审查.
探索针对癌症免疫治疗中的NY-ESO-1的各种策略.
分析采用T细胞疗法和创新技术以提高疗效.

主要方法:

对NY-ESO-1免疫性和向策略的现有文献的审查.
对各种癌症疫苗接种方法 (,蛋白,DNA,mRNA,载体,树突细胞,人工辅助载体细胞) 的分析.
深入研究采用T细胞疗法,包括下一代产品和淋巴结向疫苗.

主要成果:

纽约-ESO-1显示出高免疫性,激活内源树突细胞,T细胞和B细胞.
基于NY-ESO-1的疫苗 (蛋白质/,RNA/DNA,微生物载体,人工辅助载体细胞) 在增强抗瘤免疫反应方面表现有前途.
针对NY-ESO-1的T细胞疗法,包括工程T细胞和NK细胞,提高了免疫疗法的疗效.

结论:

NY-ESO-1是一种高度免疫的标,具有癌症免疫治疗的巨大潜力.
多种疫苗接种和采用T细胞策略有效地利用免疫系统对抗NY-ESO-1-表达瘤.
在NY-ESO-1特异性免疫治疗中不断的创新为未来的癌症治疗提供了有前途的途径.

关键词:

纽约 - ESO - 1 - 一个.癌症免疫疗法免疫疗法癌症丸抗原抗原癌症疫苗疫苗癌症疫苗瘤微环境是一个微环境.

更多相关视频

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...